EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus

Lisbet Westergaard, Lene Alifrangis, Stephen T Buckley, Hans Veit Coester, Thomas Klitgaard, Niels R Kristensen, Erica Nishimura, Lea Nørgreen, Thaís M P Rocha, Dorte B Steensgaard, Andreas Vegge, Leona Plum-Mörschel

Clinical Drug Investigation · 2024

DOI: 10.1007/s40261-024-01405-8 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Lisbet Westergaard und 11 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk, Development, Søborg, Denmark. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Diabetes Mellitus, Type 2, Cross-Over Studies, Hypoglycemic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesDiabetes Mellitus, Type 2Cross-Over StudiesHypoglycemic AgentsHumansMiddle AgedMaleAdultFemaleDouble-Blind MethodYoung AdultAdolescentDrug CombinationsInjections, SubcutaneousDrug Administration ScheduleInsulinSemaglutide

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsDrug CombinationsInsulinSemaglutide

Autor:innen und Institutionen

  • Novo Nordisk, Development, Søborg, Denmark.
  • Novo Nordisk, Research and Early Development, Måløv, Denmark.
  • Profil, Neuss, Germany.
  • Novo Nordisk, Development, Aalborg, Denmark.
  • Profil, Neuss, Germany. leona.plum-moerschel@profil.com.

Förderung

  • Novo Nordisk

Zitieren

APA

Westergaard, L., Alifrangis, L., Buckley, S. T., Coester, H. V., Klitgaard, T., Kristensen, N. R., Nishimura, E., Nørgreen, L., Rocha, T. M. P., Steensgaard, D. B., Vegge, A., & Plum-Mörschel, L. (2024). Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01405-8

Vancouver

Westergaard L, Alifrangis L, Buckley ST, Coester HV, Klitgaard T, Kristensen NR, et al. Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01405-8

BibTeX
@article{Westergaard2024,
  author = {Westergaard, Lisbet and Alifrangis, Lene and Buckley, Stephen T and Coester, Hans Veit and Klitgaard, Thomas and Kristensen, Niels R and Nishimura, Erica and Nørgreen, Lea and Rocha, Thaís M P and Steensgaard, Dorte B and Vegge, Andreas and Plum-Mörschel, Leona},
  title = {Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus},
  journal = {Clinical Drug Investigation},
  year = {2024},
  doi = {10.1007/s40261-024-01405-8}
}
Kostenlos starten →